Expertise in
3
conditions

Eduardo Arboli-Rodriguez

Sevilla, AN, ES 
Expertise in
3
conditions
Sevilla, AN, ES 

Overview

Eduardo Arboli-Rodriguez practices practicing medicine in Sevilla, Spain.

Mr. Arboli-Rodriguez is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Sevilla, AN, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1b/ 2a Pilot Trial of the Oral Hedgehog Signalling Inhibitor Glasdegib in Patients With Sclerotic Chronic Graft-Versus-Host Disease Refractory to Second-Line Treatment
A Phase 1b/ 2a Pilot Trial of the Oral Hedgehog Signalling Inhibitor Glasdegib in Patients With Sclerotic Chronic Graft-Versus-Host Disease Refractory to Second-Line Treatment
Enrollment Status: Unknown
Publish Date: March 17, 2022
Intervention Type: Drug
Study Drug: Glasdegib
Study Phase: Phase 1/Phase 2

57 Total Publications

Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study.
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study.
Journal: Haematologica
Published: July 07, 2026

Frequently Asked Questions about Eduardo Arboli-Rodriguez

Is Eduardo Arboli-Rodriguez a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Eduardo Arboli-Rodriguez is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eduardo Arboli-Rodriguez participate in research or clinical trials?

Yes. Eduardo Arboli-Rodriguez has published 57 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Eduardo Arboli-Rodriguez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arboli-Rodriguez's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile